Duloxetine FDA Approved for Pediatric Fibromyalgia (age 13-17 yr)
FDA has expanded the duloxetine indication for the treatment of fibromyalgia in pediatric population (age 13-17 yr). Duloxetine is now approved for following disorders: Major…
FDA has expanded the duloxetine indication for the treatment of fibromyalgia in pediatric population (age 13-17 yr). Duloxetine is now approved for following disorders: Major…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.